$STAA News

Stifel Maintains Hold on Staar Surgical, Lowers Price Target to $28

UBS Maintains Sell on Staar Surgical, Lowers Price Target to $19

Wedbush Maintains Outperform on Staar Surgical, Lowers Price Target to $37

STAAR Surgical Company (STAA) Q2 2026 Earnings Call Transcript

Staar Surgical Q2 EPS $0.16 Beats $0.15 Estimate, Sales $93.535M Beat $90.589M Estimate

STAAR Surgical Appoints Warren Foust As President And CEO, Effective August 4; Names Deborah Andrews EVP And CFO

Wedbush Reiterates Outperform on Staar Surgical, Maintains $40 Price Target

Wedbush Reiterates Outperform on Staar Surgical, Maintains $40 Price Target

STAAR Surgical's Punishment For Opacity Is Just

Caution Lingers for STAAR Surgical Amid Middle East Geopolitical Tensions

STAAR Surgical Reports Q2 Preliminary Net Sales To Be Over $90M

Wedbush Reiterates Outperform on Staar Surgical, Maintains $40 Price Target

3 Reasons to Avoid STAA and 1 Stock to Buy Instead

Medical Devices & Supplies - Specialty Stocks Q1 Earnings: STAAR Surgical (NASDAQ:STAA) Firing on All Cylinders

How The STAAR Surgical (STAA) Story Is Shifting After Q1 And New Analyst Targets

Wedbush Reiterates Outperform on Staar Surgical, Maintains $40 Price Target

STAAR Surgical Company (STAA) Discusses Differentiation of EVO ICL Technology and Market Trends in Refractive Surgery Transcript

STAAR Surgical Announces Participation in Upcoming Investor Conferences

5 Must-Read Analyst Questions From STAAR Surgical’s Q1 Earnings Call

STAAR Surgical signals standalone strength as Alcon overhang fades after strong Q1